Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Smart adjuvants.

Clint S Schmidt¹, W John W Morrow, Nadeem A Sheikh

¹Scientist II, Dendreon Corporation, 3005 1st Avenue, Seattle, WA 98121, USA. cschmidt@dendreon.com

Expert Review of Vaccines

|June 5, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials.

Clinical cancer research : an official journal of the American Association for Cancer Research·2023

Same author

Management of externally manufactured cell therapy products: the Mayo Clinic approach.

Cytotherapy·2022

Same author

Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens.

Journal of the National Cancer Institute·2021

Same author

Long-term Sculpting of the B-cell Repertoire following Cancer Immunotherapy in Patients Treated with Sipuleucel-T.

Cancer immunology research·2020

Same author

Fecaloma presenting as huge abdominal mass.

JGH open : an open access journal of gastroenterology and hepatology·2020

Same author

Putting the Pieces Together: Completing the Mechanism of Action Jigsaw for Sipuleucel-T.

Journal of the National Cancer Institute·2020

Same journal

Projected health and economic impact of PCV20 vaccination in UK children: a dynamic transmission model.

Expert review of vaccines·2026

Same journal

Evaluating the societal value of adult respiratory vaccination in Sweden: a benefit-cost analysis.

Expert review of vaccines·2026

Same journal

Evaluating the socioeconomic value of adult respiratory immunization in Spain: a benefit-cost analysis.

Expert review of vaccines·2026

Same journal

Whole cell and acellular pertussis vaccines - rethinking the evidence.

Expert review of vaccines·2026

Same journal

Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using an adapted COVID-19 vaccine in the Dominican Republic.

Expert review of vaccines·2026

Same journal

Narrative shielding and prebunking: a synergistic strategy against vaccine hesitancy in pediatrics.

Expert review of vaccines·2026

See all related articles

New

Area of Science:

Immunology
Vaccinology

Background:

Alum is the sole FDA-approved vaccine adjuvant, despite its limitations.
Existing adjuvants often cause general inflammation and lack specificity.
Toxicity and restricted immune responses (T-helper 2) limit current adjuvant use.

Purpose of the Study:

To review novel vaccine adjuvants with targeted immune modulation.
To introduce the concept of 'smart adjuvants' for improved vaccine strategies.

Main Methods:

Literature review of immunological advances in adjuvant development.
Categorization of novel adjuvants based on targeted immune components (cells, receptors, pathways).

Main Results:

Emerging adjuvants offer controlled and specific immune response modulation.

Related Experiment Videos

These novel candidates possess better-defined mechanisms of action.

Several compounds targeting specific immune elements are identified as 'smart adjuvants'.

Conclusions:

Smart adjuvants represent a promising advancement over traditional options.
Targeted immunomodulation by novel adjuvants enhances vaccine efficacy and safety.
These agents are crucial for developing next-generation vaccines.